La adquisición de acciones de IntegraGen por parte de OncoDNA arranca con éxito

by OncoDNA

Onco​DNA, compañía especializada en medicina de precisión para el tratamiento y diagnóstico del cáncer, ha puesto en marcha con éxito su oferta pública de adquisición (OPA) amistosa lanzada ...

Read more

ONCODNA provides an update about the friendly takeover bid on INTEGRAGEN

by OncoDNA

OncoDNA SA has become the first shareholder of IntegraGen SA (Paris: ALINT), holding 29.99% of the existing shares, as result of purchases of shares on the Euronext Growth market .

Read more

Agreement to file a friendly takeover bid initiated by OncoDNA on IntegraGen to acquire all outstanding shares at a price of 2.20€ per share

by OncoDNA

This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both c...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio preclínico mejora el tratami...

by CIMA - Centro de Investigación Médica Aplicada

Investigadores del Cima Universidad de Navarra constatan que la combin...

Photos Stream